Literature DB >> 26203188

Proteomic and Metabolic Analyses of S49 Lymphoma Cells Reveal Novel Regulation of Mitochondria by cAMP and Protein Kinase A.

Andrea Wilderman1, Yurong Guo2, Ajit S Divakaruni1, Guy Perkins3, Lingzhi Zhang1, Anne N Murphy1, Susan S Taylor4, Paul A Insel5.   

Abstract

Cyclic AMP (cAMP), acting via protein kinase A (PKA), regulates many cellular responses, but the role of mitochondria in such responses is poorly understood. To define such roles, we used quantitative proteomic analysis of mitochondria-enriched fractions and performed functional and morphologic studies of wild-type (WT) and kin(-) (PKA-null) murine S49 lymphoma cells. Basally, 75 proteins significantly differed in abundance between WT and kin(-) S49 cells. WT, but not kin(-), S49 cells incubated with the cAMP analog 8-(4-chlorophenylthio)adenosine cAMP (CPT-cAMP) for 16 h have (a) increased expression of mitochondria-related genes and proteins, including ones in pathways of branched-chain amino acid and fatty acid metabolism and (b) increased maximal capacity of respiration on branched-chain keto acids and fatty acids. CPT-cAMP also regulates the cellular rate of ATP-utilization, as the rates of both ATP-linked respiration and proton efflux are decreased in WT but not kin(-) cells. CPT-cAMP protected WT S49 cells from glucose or glutamine deprivation, In contrast, CPT-cAMP did not protect kin(-) cells or WT cells treated with the PKA inhibitor H89 from glutamine deprivation. Under basal conditions, the mitochondrial structure of WT and kin(-) S49 cells is similar. Treatment with CPT-cAMP produced apoptotic changes (i.e. decreased mitochondrial density and size and loss of cristae) in WT, but not kin(-) cells. Together, these findings show that cAMP acts via PKA to regulate multiple aspects of mitochondrial function and structure. Mitochondrial perturbation thus likely contributes to cAMP/PKA-mediated cellular responses.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  cell metabolism; cyclic AMP (cAMP); mitochondria; protein kinase A (PKA); proteomics

Mesh:

Substances:

Year:  2015        PMID: 26203188      PMCID: PMC4571978          DOI: 10.1074/jbc.M115.658153

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

1.  Integrated genomic and proteomic analyses of gene expression in Mammalian cells.

Authors:  Qiang Tian; Serguei B Stepaniants; Mao Mao; Lee Weng; Megan C Feetham; Michelle J Doyle; Eugene C Yi; Hongyue Dai; Vesteinn Thorsson; Jimmy Eng; David Goodlett; Joel P Berger; Bert Gunter; Peter S Linseley; Roland B Stoughton; Ruedi Aebersold; Steven J Collins; William A Hanlon; Leroy E Hood
Journal:  Mol Cell Proteomics       Date:  2004-07-06       Impact factor: 5.911

2.  Cultured S49 mouse T lymphoma cells.

Authors:  T van Daalen Wetters; P Coffino
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

3.  Etomoxir, a carnitine palmitoyltransferase I inhibitor, protects hearts from fatty acid-induced ischemic injury independent of changes in long chain acylcarnitine.

Authors:  G D Lopaschuk; S R Wall; P M Olley; N J Davies
Journal:  Circ Res       Date:  1988-12       Impact factor: 17.367

4.  Growth of S49 wild type cells in 3 nM epinephrine increases cyclic AMP phosphodiesterase activity.

Authors:  M D Richardson; T J Goka; R Barber; R W Butcher
Journal:  Life Sci       Date:  1994       Impact factor: 5.037

5.  A structural gene mutation affecting the regulatory subunit of cyclic AMP-dependent protein kinase in mouse lymphoma cells.

Authors:  J Hochman; P A Insel; H R Bourne; P Coffino; G M Tomkins
Journal:  Proc Natl Acad Sci U S A       Date:  1975-12       Impact factor: 11.205

6.  Cyclic AMP-dependent protein kinase: pivotal role in regulation of enzyme induction and growth.

Authors:  P A Insel; H R Bourne; P Coffino; G M Tomkins
Journal:  Science       Date:  1975-11-28       Impact factor: 47.728

7.  The mitochondrial pyruvate carrier. Kinetics and specificity for substrates and inhibitors.

Authors:  A P Halestrap
Journal:  Biochem J       Date:  1975-04       Impact factor: 3.857

8.  Kinetic properties of "soluble" adenylyl cyclase. Synergism between calcium and bicarbonate.

Authors:  Tatiana N Litvin; Margarita Kamenetsky; Alla Zarifyan; Jochen Buck; Lonny R Levin
Journal:  J Biol Chem       Date:  2003-02-27       Impact factor: 5.157

9.  The pro-apoptotic protein Bim is a convergence point for cAMP/protein kinase A- and glucocorticoid-promoted apoptosis of lymphoid cells.

Authors:  Lingzhi Zhang; Paul A Insel
Journal:  J Biol Chem       Date:  2004-03-02       Impact factor: 5.157

10.  Anti-proliferative effects of 8-chloro-cAMP and other cAMP analogs are unrelated to their effects on protein kinase A regulatory subunit expression.

Authors:  Darija Lamb; Robert A Steinberg
Journal:  J Cell Physiol       Date:  2002-08       Impact factor: 6.384

View more
  6 in total

1.  HK2 Recruitment to Phospho-BAD Prevents Its Degradation, Promoting Warburg Glycolysis by Theileria-Transformed Leukocytes.

Authors:  Malak Haidar; Anne Lombès; Frédéric Bouillaud; Eileen J Kennedy; Gordon Langsley
Journal:  ACS Infect Dis       Date:  2017-01-24       Impact factor: 5.084

Review 2.  cAMP Signaling in Cancer: A PKA-CREB and EPAC-Centric Approach.

Authors:  Muhammad Bilal Ahmed; Abdullah A A Alghamdi; Salman Ul Islam; Joon-Seok Lee; Young-Sup Lee
Journal:  Cells       Date:  2022-06-24       Impact factor: 7.666

3.  Mechanisms of cyclic AMP/protein kinase A- and glucocorticoid-mediated apoptosis using S49 lymphoma cells as a model system.

Authors:  Malik M Keshwani; Joan R Kanter; Yuliang Ma; Andrea Wilderman; Manjula Darshi; Paul A Insel; Susan S Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-28       Impact factor: 11.205

4.  In situ measurements of mitochondrial matrix enzyme activities using plasma and mitochondrial membrane permeabilization agents.

Authors:  Ajit S Divakaruni; Alexander Y Andreyev; George W Rogers; Anne N Murphy
Journal:  Anal Biochem       Date:  2017-10-04       Impact factor: 3.365

5.  The single cyclic nucleotide-specific phosphodiesterase of the intestinal parasite Giardia lamblia represents a potential drug target.

Authors:  Stefan Kunz; Vreni Balmer; Geert Jan Sterk; Michael P Pollastri; Rob Leurs; Norbert Müller; Andrew Hemphill; Cornelia Spycher
Journal:  PLoS Negl Trop Dis       Date:  2017-09-15

6.  Mutant GNAS drives pancreatic tumourigenesis by inducing PKA-mediated SIK suppression and reprogramming lipid metabolism.

Authors:  Krushna C Patra; Yasutaka Kato; Yusuke Mizukami; Sebastian Widholz; Myriam Boukhali; Iulia Revenco; Elizabeth A Grossman; Fei Ji; Ruslan I Sadreyev; Andrew S Liss; Robert A Screaton; Kei Sakamoto; David P Ryan; Mari Mino-Kenudson; Carlos Fernandez-Del Castillo; Daniel K Nomura; Wilhelm Haas; Nabeel Bardeesy
Journal:  Nat Cell Biol       Date:  2018-06-25       Impact factor: 28.824

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.